Bliss GVS Pharma Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the stock exchanges about arbitration proceedings it initiated against Pan Pharmaceuticals Limited, based in Nairobi, Kenya, to recover outstanding dues. The company filed a petition before the Supreme Court of India seeking appointment of an arbitrator. The expected recovery from the arbitration is estimated at USD 1.69 million (approximately Rs 14 crore). The company has already made provisions in its books for the receivable amount, meaning any adverse financial impact is expected to be minimal. The outcome of the arbitration will determine the final quantum of recovery.
Neutral to mildly positive for shareholders — the company is actively pursuing recovery of dues, and since provisions are already in place, there is limited downside risk from this litigation. A favourable arbitration outcome could result in a write-back of provisions and a small positive impact on earnings.